Addison Advisors LLC Grows Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Addison Advisors LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 23.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 374 shares of the healthcare conglomerate’s stock after purchasing an additional 70 shares during the period. Addison Advisors LLC’s holdings in UnitedHealth Group were worth $197,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Verdence Capital Advisors LLC increased its holdings in UnitedHealth Group by 2.1% in the 4th quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock valued at $8,919,000 after purchasing an additional 342 shares during the last quarter. Ascension Capital Advisors Inc. acquired a new stake in UnitedHealth Group in the 3rd quarter valued at approximately $216,000. Bellecapital International Ltd. increased its holdings in UnitedHealth Group by 1.4% in the 4th quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock valued at $7,277,000 after purchasing an additional 193 shares during the last quarter. Great Valley Advisor Group Inc. lifted its holdings in UnitedHealth Group by 5.8% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock worth $17,292,000 after buying an additional 1,884 shares in the last quarter. Finally, Rise Advisors LLC lifted its holdings in UnitedHealth Group by 326.0% during the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock worth $112,000 after buying an additional 163 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded up $1.49 during midday trading on Friday, hitting $495.35. 2,727,016 shares of the company’s stock were exchanged, compared to its average volume of 5,623,667. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The stock has a market cap of $455.76 billion, a price-to-earnings ratio of 30.28, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54. The firm’s 50 day simple moving average is $485.84 and its 200 day simple moving average is $514.21.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter last year, the business earned $6.26 EPS. The business’s revenue was up 8.6% on a year-over-year basis. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Barclays increased their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective on the stock in a research report on Thursday, April 4th. Finally, TD Cowen dropped their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.